SEC Form 4 · accession 0000899243-16-024745
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason B. Shandell
Officer — President and General Counsel · Director
Period of report
Jul 5, 2016
Accepted (ET)
Jul 7, 2016 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 5, 2016 | F | 3,394 | $16.33 | D | 214,584 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of deferred stock units, or DSUs.
- F2Includes 1,368 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan.